Author/Authors :
Akbarzadeh، Ladan نويسنده Department of Pharmacology, Shahid Beheshti University, Tehran, IR Iran , , Moini-Zanjani، Taraneh نويسنده Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran , , Sabetkasaei، Masoumeh نويسنده , , Khazaei Poul، Yalda نويسنده Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran ,
Abstract :
Amyloid precursor protein (APP), which is involved in cell proliferation, is observed to be over expressed in human cancer. Thus, it is crucial to investigate its role in cancer and suggest treatment strategies to alter its effects on cell growth. The main purpose of this study was to determine APP concentrations in colon cancer SW480 cell line after treatment with histone deacetylase inhibitors (HDACIs), namely valproic acid (VPA) and carbamazepine (CBZ). In the present experimental study, carried out during the period 2014 - 2016 in Iran, 1000000 cells were seeded and incubated in a six-well plate for each sample preparation. The cells were then treated with drugs and APP was evaluated. The concentration of this protein was detected using the enzyme-linked immunosorbent assay (ELISA) method. We found that treatment with CBZ (P < 0.001) and VPA (P < 0.001) reduced the APP levels significantly compared to controls. The APP level reduction by CBZ was 41.6% more than that by VPA. The results of this study suggest that APP reduction by HDACIs can apparently play an important role in the treatment of colon cancer.
